thesis explores preeclampsia as a major hypertensive disorder of pregnancy causing high maternal and fetal morbidity and mortality. It explains that abnormal placentation, oxidative stress, and immune imbalance drive the disease. Diagnostic criteria from ACOG and ISSHP are outlined alongside clinical features and complications like HELLP syndrome. The core focus is on pharmacologic management, including labetalol, nifedipine, methyldopa, hydralazine, and magnesium sulfate. Corticosteroids for fetal lung maturity and postpartum monitoring are also discussed. The thesis concludes by emphasizing early detection, individualized care, and the need for improved therapeutic strategies.